Youcare
688658.SSYoucare Pharmaceutical Group Co., Ltd. Price (688658.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
450,721,267
(0.1603)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Youcare Pharmaceutical Group Co., Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
2,700,086,378.00
+0% |
3,982,702,543.00
+48% |
4,287,579,921.00
+8% |
4,338,949,010.00
+1% |
4,965,725,984.00
+14% |
4,541,945,402.00
-9% |
4,196,300,747.00
-8% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 1,538,299,860.00 | 1,585,607,845.00 | 1,675,629,906.00 | 1,474,601,896.00 | 1,527,355,452.00 | 1,605,794,722.00 | 1,621,872,632.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
1,161,786,518.00
+0% |
2,397,094,698.00
+106% |
2,611,950,015.00
+9% |
2,864,347,114.00
+10% |
3,438,370,532.00
+20% |
2,936,150,680.00
-15% |
2,574,428,115.00
-12% |
||||||||||||
| Gross Profit Ratio | (0.43%) | (0.60%) | (0.61%) | (0.66%) | (0.69%) | (0.65%) | (0.61%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 81,675,186.00 | 98,101,269.00 | 126,186,172.00 | 127,894,940.00 | 200,031,843.00 | 344,415,703.00 | 351,879,003.00 | ||||||||||||
| General and Administrative | 49,112,287.00 | 35,519,932.00 | 40,208,974.00 | 40,198,072.00 | 40,666,383.00 | 53,621,553.00 | 47,955,428.00 | ||||||||||||
| Selling, General & Admin... | 701,405,498.00 | 1,755,306,045.00 | 1,921,456,698.00 | 2,056,659,627.00 | 2,397,050,319.00 | 2,050,481,439.00 | 1,968,927,549.00 | ||||||||||||
| Selling & Marketing Exp... | 652,293,211.00 | 1,719,786,112.00 | 1,881,247,724.00 | 2,016,461,555.00 | 2,356,383,935.00 | 1,996,859,885.00 | 1,781,859,792.00 | ||||||||||||
| Depreciation and Amortiz... | 111,459,300.00 | 118,234,900.00 | 129,830,600.00 | 134,237,926.00 | 141,515,204.00 | 165,769,591.00 | 180,637,024.00 | ||||||||||||
| Other Expenses | 10,087,898.00 | 1,454,899.00 | 170,917,864.00 | 128,643,558.00 | 178,891,115.00 | 121,478,411.00 | 21,868,813.00 | ||||||||||||
| Total Operating Expenses | 918,730,369.00 | 2,017,630,794.00 | 2,218,560,735.00 | 2,313,198,126.00 | 2,775,973,278.00 | 2,516,375,554.00 | 2,342,675,365.00 | ||||||||||||
| Cost and Exponses | 2,457,030,229.00 | 3,603,238,640.00 | 3,894,190,641.00 | 3,787,800,023.00 | 4,303,328,730.00 | 4,122,170,276.00 | 3,964,547,997.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
188,948,044.00
+0% |
323,410,362.00
+71% |
328,058,787.00
+1% |
492,150,065.00
+50% |
636,823,088.00
+29% |
357,940,500.00
-44% |
231,752,750.00
-35% |
||||||||||||
| Operating Income Ratio | (0.07%) | (0.08%) | (0.08%) | (0.11%) | (0.13%) | (0.08%) | (0.06%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 40,074,752.00 | 7,633,742.00 | 1,924,907.00 | 2,041,274.00 | 31,148,652.00 | 28,272,575.00 | 23,402,314.00 | ||||||||||||
| Interest Expenses | 110,251,616.00 | 40,936,381.00 | 36,415,514.00 | 25,068,100.00 | 3,473,494.00 | 4,697,349.00 | 14,456,437.00 | ||||||||||||
| Total Other Income/Exp... | 10,087,899.00 | 1,454,899.00 | 3,708,685.00 | 2,986,488.00 | -7,551,274.00 | -8,414,690.00 | -8,484,487.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 422,722,162.00 | 485,731,242.00 | 499,926,663.00 | 657,942,768.00 | 775,438,278.00 | 521,075,655.00 | 418,361,727.00 | ||||||||||||
| EBITDA ratio | (0.12%) | (0.11%) | (0.10%) | (0.15%) | (0.17%) | (0.14%) | (0.10%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 199,035,943.00 | 324,865,261.00 | 331,767,472.00 | 495,136,553.00 | 629,271,814.00 | 349,525,810.00 | 223,268,263.00 | ||||||||||||
| Income Before Tax Ratio | (0.07%) | (0.08%) | (0.08%) | (0.11%) | (0.13%) | (0.08%) | (0.05%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 38,161,559.00 | 55,966,409.00 | 43,973,186.00 | 51,508,654.00 | 85,548,951.00 | 10,789,605.00 | 35,774,173.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 161,561,304.00
+0% |
267,949,096.00
+66% |
285,454,044.00
+7% |
442,136,589.00
+55% |
545,316,048.00
+23% |
335,184,883.00
-39% |
184,795,719.00
-45% |
||||||||||||
| Net Income Ratio | (0.06%) | (0.07%) | (0.07%) | (0.10%) | (0.11%) | (0.07%) | (0.04%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.45 | 0.74 | 0.63 | 0.98 | 1.21 | 0.74 | 0.41 | ||||||||||||
| Diluted EPS | 0.45 | 0.74 | 0.63 | 0.98 | 1.21 | 0.74 | 0.41 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 361,334,234.00 | 361,334,234.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,721,267.00 | ||||||||||||
| Diluted Share Outstanding | 361,334,234.00 | 361,334,234.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,721,267.00 | ||||||||||||